Indian, UK COVID Variants Detected in S.Africa

In South Africa, fifteen cases of the Indian and British Covid-19 variants have been detected, Health Minister Zweli Mkhize said.

Of all the 11 cases of the B.1.1.7 variant which was first detected in the UK, eight were reported in the Western Cape, one in KwaZulu-Natal and two in Gauteng.

COVID Deaths Cross 75K in Maharashtra
In Maharashtra COVID-19 case tally has crossed the 5 million-mark while fatalities shot past the 75,000-level, although the situation in Mumbai remained positive, health officials said here.

‘According to Mkhize, the Network for Genomic Surveillance in South Africa confirmed four cases of the B.1.617.2 variant, which was first detected in India, were registered in Gauteng and KwaZulu-Natal and all the infected persons had a recent history of travelling from the South Asian nation.’

Mkhize said the British variant was spreading in the community.

"The B.1.1.7 variant has been detected in community samples and this therefore suggests that community transitions has already set it," he said.

The National Institute for Communicable Diseases (NICD) said that work focusing on the variants is being done.

Study Shows Why Some Patients Test Positive for COVID Long After Recovery
Some virus RNA are reverse transcribed which helps explain why some people who had already recovered from Covid-19 would sometimes inexplicably test positive on a PCR test weeks or even months later.

"We would like to assure the public that the institute is focusing their resources and research efforts towards understanding the variants and what the potential implications are for South Africa," said Professor Adrian Puren, the NICD's Acting Executive Director.

South Africa has so far recorded 1,594,817 Covid-19 cases with 54,724 deaths.

COVID-19 is Airborne, Says US CDC
Exposure to respiratory fluids present in air and which which carry viruses are the key reasons for contracting COVID-19 infections, the US Centers for Disease Control and Prevention (CDC) said.

Source-IANS

Painkiller Ibuprofen Doesn't Raise COVID Death Risk
Ibuprofen, the non-steroidal anti-inflammatory drug (NSAID) is safe and does not lead to higher rates of death or severe disease in patients hospitalized with COVID-19.